Indeed, alteration of the histone acetyltransferase (HAT)/HDAC balance towards elevated histone deacetylation and enhanced transcription of tumor suppressor genes is well documented in bladder cancer [17]. The gene discussed is HDAC9; the disease is urinary bladder carcinoma.